Dates
Competition closes: 18 September 2024 1:00pm BST
Applications open: 31 July 2024
Selection Panel: December 2024
Project start date: January – February 2025
Scope
Competition aim is to facilitate the collection of evidence in real-world settings and build on the value proposition required by commissioners and regulators for technology’s uptake. The competition is open to any innovation (e.g., medical device, in-vitro diagnostic, digital health/ AI solutions, behavioural interventions, and service improvements) that meets the entry criteria and one of the challenges described below.
Specific Themes
SBRI Healthcare Phase 3 seeks to address challenges in Urgent and Emergency Care and aims to identify solutions at an advanced stage of development: 1. Health and Care outside of Hospitals: Accessing the Right Care and Reducing Demand 2. Reducing Length of Stay and Improving Discharge 3. Supporting Workforce.
Projects that will not be funded
- Basic research and innovations in the creation phase.
- Systems and solutions that will not easily integrate or communicate with NHS/community setting systems. Some evidence of interoperability and/or work to assess this will be required.
- Technologies that do not comply with GDPR policies.
- Technologies that may increase burden on the workforce.
- Technologies that will exacerbate health inequalities (including digital exclusion or data inequalities) and inequity of access to care e.g., digital technologies that are inaccessible to certain communities that experience digital poverty.
- Innovations that are not co-designed with patients and end users.
- Electric Ambulances.
Eligibility
- UKCA marked.
- If CE-marked only, a clear timeline to achieve UKCA mark by June 2028 (general medical devices) or June 2030 (in vitro diagnostic medical devices). If regulatory approval is not yet obtained, evidence should be provided to demonstrate that the innovation is close to obtaining approval and/or in use in at least one NHS Hospital Trust.
- Clinical efficacy and safety demonstrated through an appropriate and relevant clinical evaluation.
- All projects must demonstrate relevant partnerships with a clinical partner and service(s)/clinical sites lined up.
- Projects are strongly encouraged to conduct an independent evaluation.
- For digital solutions, evidence that the technology has passed or is close to passing the necessary information governance and cyber security requirements where relevant. Evidence that the NHS England Digital Technology Assessment Criteria (DTAC) has been considered.
Funding Rates
The Phase 3 funding – one phase only and is intended to facilitate the implementation of developed innovations. Contracts will be for a maximum of 12 months and up to £500,000 (NET) per project. Projects are 100% funded and suppliers for each project will be selected by an open competition process and retain the intellectual property rights (IPR) generated from the project, with certain rights of use retained by the NHS.
How PNO can support you
The UK team has a strong track record in securing some of the most competitive national and European grants on behalf of its clients, with a full understanding of how a project should be presented to stand the highest chance of success. Each year in the UK alone, we are responsible for the submission of more than 100 funding applications across all sectors and priority areas. Based on this extensive experience, through careful project selection and using key insight into how a project should be best positioned, we consistently achieve success rates that are more than 5 times the typical success rates for UK national schemes and EU programmes.
